These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25333200)

  • 1. Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease?
    Chouinard-Watkins R; Plourde M
    Nutrients; 2014 Oct; 6(10):4452-71. PubMed ID: 25333200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Diet Rich in Docosahexaenoic Acid Restores Liver Arachidonic Acid and Docosahexaenoic Acid Concentrations in Mice Homozygous for the Human Apolipoprotein E ε4 Allele.
    Chouinard-Watkins R; Pinçon A; Coulombe JD; Spencer R; Massenavette L; Plourde M
    J Nutr; 2016 Jul; 146(7):1315-21. PubMed ID: 27306896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
    Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
    J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoE4 May be a Promising Target for Treatment of Coronary Heart Disease and Alzheimer's Disease.
    Chen W; Jin F; Cao G; Mei R; Wang Y; Long P; Wang X; Ge W
    Curr Drug Targets; 2018; 19(9):1038-1044. PubMed ID: 29623835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE ε4 allele.
    Chouinard-Watkins R; Rioux-Perreault C; Fortier M; Tremblay-Mercier J; Zhang Y; Lawrence P; Vohl MC; Perron P; Lorrain D; Brenna JT; Cunnane SC; Plourde M
    Br J Nutr; 2013 Nov; 110(10):1751-9. PubMed ID: 23631810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
    Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
    BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.
    Yassine HN; Braskie MN; Mack WJ; Castor KJ; Fonteh AN; Schneider LS; Harrington MG; Chui HC
    JAMA Neurol; 2017 Mar; 74(3):339-347. PubMed ID: 28114437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.
    Vandal M; Alata W; Tremblay C; Rioux-Perreault C; Salem N; Calon F; Plourde M
    J Neurochem; 2014 May; 129(3):516-26. PubMed ID: 24345162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men.
    Plourde M; Vohl MC; Vandal M; Couture P; Lemieux S; Cunnane SC
    Br J Nutr; 2009 Oct; 102(8):1121-4. PubMed ID: 19828088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE and the Association of Fatty Acids With the Risk of Stroke, Coronary Heart Disease, and Mortality.
    Satizabal CL; Samieri C; Davis-Plourde KL; Voetsch B; Aparicio HJ; Pase MP; Romero JR; Helmer C; Vasan RS; Kase CS; Debette S; Beiser AS; Seshadri S
    Stroke; 2018 Dec; 49(12):2822-2829. PubMed ID: 30571417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.
    Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T
    Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline.
    Nock TG; Chouinard-Watkins R; Plourde M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Oct; 1862(10 Pt A):1068-1078. PubMed ID: 28733268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer's disease pathogenesis.
    Zhu L; Zhong M; Elder GA; Sano M; Holtzman DM; Gandy S; Cardozo C; Haroutunian V; Robakis NK; Cai D
    Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11965-70. PubMed ID: 26372964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of DHA on cognitive dysfunction in aging and Alzheimer's disease: The mediating roles of ApoE.
    Zhang X; Yuan T; Chen X; Liu X; Hu J; Liu Z
    Prog Lipid Res; 2024 Jan; 93():101256. PubMed ID: 37890592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.
    Chételat G; Fouquet M
    Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.
    Barberger-Gateau P; Samieri C; Féart C; Plourde M
    Curr Alzheimer Res; 2011 Aug; 8(5):479-91. PubMed ID: 21605054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the apolipoprotein E ε4 allele on functional MRI during n-back working memory tasks in healthy middle-aged adults.
    Chen CJ; Chen CC; Wu D; Chi NF; Chen PC; Liao YP; Chiu HW; Hu CJ
    AJNR Am J Neuroradiol; 2013; 34(6):1197-202. PubMed ID: 23275593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Genomic Analysis Revealed Associated Genes for Alzheimer's Disease in APOE4 Non-Carriers.
    Jiang S; Zhang CY; Tang L; Zhao LX; Chen HZ; Qiu Y
    Curr Alzheimer Res; 2019; 16(8):753-763. PubMed ID: 31441725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.